Atlas Trials

MEmbranous Nephropathy Trial Of Rituximab

Clinical trial NCT01180036 · COMPLETED

Trial details

NCT number
NCT01180036
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Idiopathic Membranous Nephropathy
Start date
2011-11-01
Primary completion
2017-10-01
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.